Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results from a new drug study caused investors to flee the drugmaker. The Danish producer of Ozempic,
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
view original post